1. Home
  2. SANA vs IRS Comparison

SANA vs IRS Comparison

Compare SANA & IRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SANA
  • IRS
  • Stock Information
  • Founded
  • SANA 2018
  • IRS 1943
  • Country
  • SANA United States
  • IRS Argentina
  • Employees
  • SANA N/A
  • IRS N/A
  • Industry
  • SANA Medicinal Chemicals and Botanical Products
  • IRS Homebuilding
  • Sector
  • SANA Health Care
  • IRS Real Estate
  • Exchange
  • SANA Nasdaq
  • IRS Nasdaq
  • Market Cap
  • SANA 983.4M
  • IRS 1.1B
  • IPO Year
  • SANA 2021
  • IRS 1994
  • Fundamental
  • Price
  • SANA $3.91
  • IRS $14.69
  • Analyst Decision
  • SANA Strong Buy
  • IRS Strong Buy
  • Analyst Count
  • SANA 6
  • IRS 1
  • Target Price
  • SANA $10.00
  • IRS $12.62
  • AVG Volume (30 Days)
  • SANA 5.5M
  • IRS 189.7K
  • Earning Date
  • SANA 08-11-2025
  • IRS 09-02-2025
  • Dividend Yield
  • SANA N/A
  • IRS 6.77%
  • EPS Growth
  • SANA N/A
  • IRS N/A
  • EPS
  • SANA N/A
  • IRS 0.20
  • Revenue
  • SANA N/A
  • IRS $308,539,877.00
  • Revenue This Year
  • SANA N/A
  • IRS N/A
  • Revenue Next Year
  • SANA N/A
  • IRS N/A
  • P/E Ratio
  • SANA N/A
  • IRS $6.74
  • Revenue Growth
  • SANA N/A
  • IRS N/A
  • 52 Week Low
  • SANA $1.26
  • IRS $7.93
  • 52 Week High
  • SANA $7.30
  • IRS $17.67
  • Technical
  • Relative Strength Index (RSI)
  • SANA 47.52
  • IRS 47.70
  • Support Level
  • SANA $4.72
  • IRS $15.31
  • Resistance Level
  • SANA $5.33
  • IRS $16.43
  • Average True Range (ATR)
  • SANA 0.35
  • IRS 0.61
  • MACD
  • SANA -0.14
  • IRS 0.01
  • Stochastic Oscillator
  • SANA 3.40
  • IRS 20.18

About SANA Sana Biotechnology Inc.

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.

About IRS IRSA Inversiones Y Representaciones S.A. Global Depositary Shares (Each representing ten shares of)

IRSA Inversiones y Representaciones SA is engaged in a diversified business. The company's operating segment includes Shopping Malls; Offices; Sales and Developments; Hotels and others. It generates maximum revenue from the Shopping Malls segment. The Shopping Malls segment comprised of lease and service revenues related to rental of commercial space and other spaces in the shopping malls of the company.

Share on Social Networks: